Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study
Sonja Wurm, Jennifer M. Moritz, Verena Petzer, Dominik Wolf, Karoline V. Gleixner, Wolfgang R. Sperr, Christina Groiss, Sigrid Machherndl-Spandl, Gregor Eisenwort, Elisabeth Koller, Johannes Schoeche, Clemens Petrasch, Josef Singer, Daniel M. Mayer, Gudrun Pregartner
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAcute Myeloid Leukemia Research · Histone Deacetylase Inhibitors Research · Retinoids in leukemia and cellular processes